Robyn Saw, FRACS, MS, MBBS, associate professor of surgery, The University of Sydney, discusses a study of vitamin D in melanoma.

This phase II study aims to find an alternative therapy option for patients with melanoma who are at high risk for recurrence. Currently, the only option for these patients is surgery.

In the study, patients received adjuvant therapy with high-dose vitamin D following primary treatment. Vitamin D has shown potential to delay recurrence and improve prognosis. Currently, there is no effective nontoxic adjuvant therapy for this population.

Robyn Saw, FRACS, MS, MBBS

Articles

Dr. Saw Discusses Study of Vitamin D in Melanoma